Already Registered? Click Here

Given the urgent need to shorten timelines and lower costs for biologics such as monoclonals (specially biosimilars) as well as address the demand for complex proteins such as bispecific antibodies, the biopharma industry is re-evaluating traditional manufacturing methods that have been a staple of drug development for decades. Developing new therapy modalities requires sustainable strategies and technologies that maximize production. To tackle the limitations with existing bioprocesses, manufacturers are increasingly turning to partners like Sartorius for progressive process intensification solutions and strategies to deliver the next generation of biologic drugs.

In this GEN webinar, guest speakers from Evotec Biologics, Sanofi, and Sartorius will share their insights in implementing intensified technologies and their potential to improve the efficiency and cost-effectiveness of biologics manufacturing. Key takeaways from the webinar will include:

• Innovative continuous manufacturing solutions to help biomanufacturers improve productivity
• Key considerations for adopting a process intensification strategy -- and how this can enhance process safety and enhance environmental impact
• Insights into the latest market and technology trends 

A live Q&A session will follow the presentation, offering you a chance to pose questions to our expert panelists.